Paper Status Tracking

Journals
Journal of Pharmacy and Pharmacology

Journal of Pharmacy and Pharmacology

ISSN: 2328-2150
Website:http://www.davidpublisher.com/Home/Journal/JPP
Frequency: monthly
Volume 9, Number 5, May 2021 (Serial Number 90)
About This Journal

Description

Journal of Pharmacy and Pharmacology (JPP) [ISSN 2328-2150 (Print)] is an international, scholarly peer-reviewed journal (print and online) published monthly by David Publishing Company (USA) since 2013. Now, Global Impact Factor (2014) is 0.376 and IBI Factor of Journal of Pharmacy and Pharmacology for the year 2014-15 is 3.16. The journal publishes articles, reviews, case reports, etc. JPP, USA is a multidisciplinary peer-reviewed journal published monthly is dedicated to increasing the depth of Current Research across disciplines with the ultimate aim of improving current research. The journal is published in English. The e-journal provides free and open access to all of its content on our Website. Accepted papers will immediately appear online followed by the printed in hard copy. Current columns namely: pharmacodynamics, pharmacokinetics, biopharmaceutics, pharmaceutical analysis, pharmaceutical biotechnology and drug delivery, pharmaceutical outcomes and policy, pharmacy administration, advanced pharmacology, experimental method and technique of pharmacology, clinical pharmacology, medical statistics, pathophysiology, medicinal chemistry, and so on.


Information for Authors

1. Submission of Manuscript: The manuscript should be original, and has not been published previously. Do not submit material that is currently being considered by another journal. The manuscript should be in MS Word format, submitted as an email attachment to our email address: pharmacydpc@davidpublishing.com or pharmacy@davidpublishing.com.

2. Some Requirements: Manuscripts may be 3000-12000 words or longer if approved by the editor, including an abstract, texts, tables, footnotes, appendixes and references. The title should be on page 1 and not exceed 15 words, and should be followed by an abstract of 100-200 words. 3-8 key words or key phrases are required.

3. Transfer of Copyright Agreement: Authors of the articles being accepted are required to sign up the Transfer of Copyright Agreement form.

4. Hard Copies: Author will receive 2 hard copies of the journal containing their articles (The author pays for the postage).

5. Publication Fee: Since the Journal of Pharmacy and Pharmacology publishes articles in an open access format, it does not have any income source. Publishing costs include: the cost of peer review management, journal production, and online hosting and archiving – by charging a fee for each article published (APC). The publishing fee varies according to the number of formatted pages of the article and is paid when the article is accepted and the author is willing to publish the article in our journal. Authors are also required to apply for partial waiver if they could not meet up to the processing fee, especially in developing countries such as Asia, Africa and South America nations.


Peer Review Policy

Journal of Pharmacy and Pharmacology (JPP) is a peer-review journal. All research articles in the journals undergo rigorous peer review, based on initial editor screening and refereeing by at least two anonymous referees. All manuscripts/chapters are assessed rapidly and the decision based on all the peer reviewers' comments, taken by the journal’s Editor-in-Chief/eBook Editor, is then conveyed to the author(s).


Article Withdrawal

Articles in Press (articles that have been accepted for publication or published as E-pub Ahead of Schedule but which have not been formally published with volume/issue/page information) that include errors, or are determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data or the like, may be “Withdrawn” from the journal. Withdrawal means that the article files are removed and replaced with a PDF stating that the article has been withdrawn from the journal in accordance with David Publishing Company Editorial Policies.


Editorial Procedures

All papers considered appropriate for this journal are reviewed anonymously by at least two outside reviewers. The review process usually takes two to three weeks. Papers are accepted for publication subject to no substantive, stylistic editing. The Editor reserves the right to make any necessary changes in the papers, or request the author to do so, or reject the paper submitted. A copy of the edited paper along with the first proofs will be sent to the author for proofreading. They should be corrected and returned to the Editor within seven days. Once the final version of the paper has been accepted, authors are requested not to make further changes to the text.


Statement of Human and Animal Rights

When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors must indicate whether the institutional and national guide for the care and use of laboratory animals was followed.


Informed Consent, Privacy and Confidentiality Statement

Patients and Study Participants: Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) has provided written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be published. Authors should disclose to these patients whether any potential identifiable material might be available on the internet as well as in print after publication. Patient consent should be written and archived with the journal, the authors, or both, as dictated by local regulations or laws. The Journal requires that all authors obtain written patient consent and that this be archived by the author and be made available for inspection for a period of at least three years. A written statement should be included in the manuscript that attests that the authors have obtained and archived written patient consent. Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance, and editors should also note, that such alterations do not distort scientific meaning.

Manuscripts that include human subjects must include a statement that written informed consent was obtained. If materials or records derived from humans are included, the statement that approval from an Institutional Review Board (IRB) or Ethics Committee was obtained prior to initiation of the study, if it is required by the institution. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

The use of laboratory animals must follow the standards established by the NIH Office of Animal Care and Use (OACU ARAC guidelines) and Institute for Laboratory Animal Research as published in the Guide for the Care and Use of Laboratory Animals (1996).

Manuscripts will be reviewed with due respect to author and reviewer confidentiality. Editors at the Journal of Pharmacy and Pharmacology (USA) have been instructed to not disclose information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers. Manuscripts sent for review are privileged communications. Therefore, reviewers and members of the editorial staff respect the authors’ rights by not publicly discussing the authors’ work or appropriating their ideas prior to the publication of the manuscript. Reviewers cannot make copies of the manuscript for their files and cannot share it with others, except with the editor’s permission. Reviewers have to return or destroy the copies of the manuscripts after submitting reviews.


Conflict-of-Interest Statement for Publications

A conflict of interest exists when the validity of research might be influenced by a possible financial gain or personal rivalry. It may arise for the authors of an article when their financial interest may influence their interpretation of their results or those of others.
The Editors will not reject papers simply because of a conflict of interest but believe that any competing interests should be acknowledged and openly stated prior to publication; therefore, a declaration of interest is published alongside the final published article.


Policy of Screening for Plagiarism

Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format. Plagiarism is scientific misconduct and should be addressed as such.
Self-plagiarism refers to the practice of an author using portions of their previous writings on the same topic in another of their publications, without specifically citing it formally in quotes. This practice is widespread and sometimes unintentional, as there are only so many ways to say the same thing on many occasions, particularly when writing the methods section of an article. Although this usually violates the copyright that has been assigned to the publisher, there is no consensus as to whether this is a form of scientific misconduct, or how many of one's own words one can use before it is truly plagiarism. Probably for this reason self-plagiarism is not regarded in the same light as plagiarism of ideas and words of other individuals. If journals have developed a policy on this matter, it should be clearly stated for the authors’ information.
Direct plagiarism is the plagiarism of the text. Mosaic plagiarism is the borrowing of ideas and opinions from an original source and a few verbatim words or phrases without acknowledging the author.
Authors can adhere to the following steps to report plagiarism:

1: Inform the editor of the journal where a plagiarized article is published.

2: Send original and plagiarized articles with plagiarized part highlighted.

3: If evidence of plagiarism is convincing, editor should arrange for a disciplinary meeting.

4: Editor of the journal where the plagiarized article should communicate with the editor of the journal containing the original article to rectify the matter.

5: The plagiarist should be asked to provide an explanation.

6: In case of nonresponse in the stipulated time or an unsatisfactory explanation, the article should be permanently retracted.

7: Author should be blacklisted and debarred for submitted an article to a particular journal for at least 5 years.

8: The concerned head of the institution must be notified.

Authors could check their manuscripts by: http://www.crossref.org/crosscheck/index.html or

software: http://advego.ru/plagiatus/advego_plagiatus.exe


Copyright and License

Accepted articles can be published online for free open access. Open access publishing provides maximum dissemination of the article to the largest audience.


Submission of Manuscript

All manuscripts submitted will be considered for publication. Manuscripts should be sent online or as an email attachment to: pharmacydpc@davidpublishing.com, pharmacy@davidpublishing.com, pharmacy@davidpublishing.org.

About | Terms & Conditions | Issue | Privacy | Contact us
Coryright © 2015 David Publishing Company All rights reserved, 3 Germay Dr., Unit 4 #4651, Wilmington DE 19804
Tel: 1-323-984-7526, 323-410-1082; Fax: 1-323-984-7374, 323-908-0457 , www.davidpublisher.com, Email: order@davidpublishing.com